BIT 0.00% 1.9¢ biotron limited

Major Article - BIT225, in combination with 3-drug antiretroviral therapy, page-39

  1. 2,684 Posts.
    lightbulb Created with Sketch. 739
    https://www.sciencedirect.com/science/article/abs/pii/S0166354210003414

    BIT's hepatitis C work was also peer reviewed. We all know how that turned out.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.